Researcher profile

Blanca Gallego

Blanca Gallego contributes to research discovery and scholarly infrastructure.

ResearcherAffiliation not importedOpen to collaborate

Trust snapshot

Quick read

Trust 19 - UnverifiedVerification L1Unclaimed author
5works
0followers
7topics
4close collaborators

Actions

Decide how to stay connected

Follow researcher0

Identity and collaboration

How to connect with this researcher

Claiming links this public author record to a researcher profile and unlocks direct collaboration workflows.

Log in to claim

Direct collaboration

Open a focused conversation when the fit is right

Claim this author entity first to unlock direct invitations.

Research graph

See the researcher in context

Open full explorer

Inspect adjacent work, topics, institutions and collaborators without jumping out to a separate graph page.

Building this graph slice

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

5 published item(s)

preprint2022arXiv

Assessing the effectiveness of empirical calibration under different bias scenarios

Background: Estimations of causal effects from observational data are subject to various sources of bias. One method of adjusting for the residual biases in the estimation of a treatment effect is through negative control outcomes, where the treatment does not affect the outcome. The empirical calibration procedure is a technique that uses negative controls to calibrate p-values. An extension of empirical calibration calibrates the coverage of the 95% confidence interval of a treatment effect estimate by using negative control outcomes as well as positive control outcomes (where treatment affects the outcome). Methods: The effect of empirical calibration of confidence intervals was analyzed using simulated datasets with known treatment effects. The simulations consisted of binary treatment and binary outcome, with biases resulting from unmeasured confounder, model misspecification, measurement error, and lack of positivity. The performance of the empirical calibration was evaluated by determining the change in the coverage of the confidence interval and the bias in the treatment effect estimate. Results: Empirical calibration increased coverage of the 95% confidence interval of the treatment effect estimate under most bias scenarios but was inconsistent in adjusting the bias in the treatment effect estimate. Empirical calibration of confidence intervals was most effective when adjusting for the unmeasured confounding bias. Suitable negative controls had a large impact on the adjustment made by empirical calibration, but small improvements in the coverage of the outcome of interest were also observable when using unsuitable negative controls.

preprint2022arXiv

Causal inference for observational longitudinal studies using deep survival models

Causal inference for observational longitudinal studies often requires the accurate estimation of treatment effects on time-to-event outcomes in the presence of time-dependent patient history and time-dependent covariates. To tackle this longitudinal treatment effect estimation problem, we have developed a time-variant causal survival (TCS) model that uses the potential outcomes framework with an ensemble of recurrent subnetworks to estimate the difference in survival probabilities and its confidence interval over time as a function of time-dependent covariates and treatments. Using simulated survival datasets, the TCS model showed good causal effect estimation performance across scenarios of varying sample dimensions, event rates, confounding and overlapping. However, increasing the sample size was not effective in alleviating the adverse impact of a high level of confounding. In a large clinical cohort study, TCS identified the expected conditional average treatment effect and detected individual treatment effect heterogeneity over time. TCS provides an efficient way to estimate and update individualized treatment effects over time, in order to improve clinical decisions. The use of a propensity score layer and potential outcome subnetworks helps correcting for selection bias. However, the proposed model is limited in its ability to correct the bias from unmeasured confounding, and more extensive testing of TCS under extreme scenarios such as low overlapping and the presence of unmeasured confounders is desired and left for future work.

preprint2022arXiv

TreatmentEstimatoR: a Dashboard for Estimating Treatment Effects from Observational Health Data

Observational health data can be leveraged to measure the real-world use and potential benefits or risks of existing medical interventions. However, lack of programming proficiency and advanced knowledge of causal inference methods excludes some clinicians and non-computational researchers from performing such analyses. Code-free dashboard tools provide accessible means to estimate and visualize treatment effects from observational health data. We present TreatmentEstimatoR, an R Shiny dashboard that facilitates the estimation of treatment effects from observational data without any programming knowledge required. The dashboard provides effect estimates from multiple algorithms simultaneously and accommodates binary, continuous, and time-to-event outcomes. TreatmentEstimatoR allows for flexible covariate selection for treatment and outcome models, comprehensive model performance metrics, and an exploratory data analysis tool. TreatmentEstimatoR is available at https://github.com/CollinSakal/TreatmentEstimatoR. We provide full installation instructions and detailed vignettes for how to best use the dashboard.

preprint2021arXiv

Comparing Broadband ISP Performance using Big Data from M-Lab

Comparing ISPs on broadband speed is challenging, since measurements can vary due to subscriber attributes such as operation system and test conditions such as access capacity, server distance, TCP window size, time-of-day, and network segment size. In this paper, we draw inspiration from observational studies in medicine, which face a similar challenge in comparing the effect of treatments on patients with diverse characteristics, and have successfully tackled this using "causal inference" techniques for {\em post facto} analysis of medical records. Our first contribution is to develop a tool to pre-process and visualize the millions of data points in M-Lab at various time- and space-granularities to get preliminary insights on factors affecting broadband performance. Next, we analyze 24 months of data pertaining to twelve ISPs across three countries, and demonstrate that there is observational bias in the data due to disparities amongst ISPs in their attribute distributions. For our third contribution, we apply a multi-variate matching method to identify suitable cohorts that can be compared without bias, which reveals that ISPs are closer in performance than thought before. Our final contribution is to refine our model by developing a method for estimating speed-tier and re-apply matching for comparison of ISP performance. Our results challenge conventional rankings of ISPs, and pave the way towards data-driven approaches for unbiased comparisons of ISPs world-wide.

preprint2019arXiv

Targeted Estimation of Heterogeneous Treatment Effect in Observational Survival Analysis

The aim of clinical effectiveness research using repositories of electronic health records is to identify what health interventions 'work best' in real-world settings. Since there are several reasons why the net benefit of intervention may differ across patients, current comparative effectiveness literature focuses on investigating heterogeneous treatment effect and predicting whether an individual might benefit from an intervention. The majority of this literature has concentrated on the estimation of the effect of treatment on binary outcomes. However, many medical interventions are evaluated in terms of their effect on future events, which are subject to loss to follow-up. In this study, we describe a framework for the estimation of heterogeneous treatment effect in terms of differences in time-to-event (survival) probabilities. We divide the problem into three phases: (1) estimation of treatment effect conditioned on unique sets of the covariate vector; (2) identification of features important for heterogeneity using an ensemble of non-parametric variable importance methods; and (3) estimation of treatment effect on the reference classes defined by the previously selected features, using one-step Targeted Maximum Likelihood Estimation. We conducted a series of simulation studies and found that this method performs well when either sample size or event rate is high enough and the number of covariates contributing to the effect heterogeneity is moderate. An application of this method to a clinical case study was conducted by estimating the effect of oral anticoagulants on newly diagnosed non-valvular atrial fibrillation patients using data from the UK Clinical Practice Research Datalink.